Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Inter-center comparison of good manufacturing practices-compliant stromal vascular fraction and proposal for release acceptance criteria: a review of 364 productions

Fig. 3

Free of germs and contaminated batches of the finished product and environmental monitoring within the two cohorts. A AP-HM batches were significantly less contaminated compared to SSCF batches (p = 0.0008). B No significant differences were observed for environmental monitoring, data missing for 29 patients in SSCF cohort and 12 patients in AP-HM cohort; SSCF, Swiss Stem Cell Foundation; AP-HM, Assistance Publique-Hôpitaux de Marseille

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512